Azilsartan Impurity A | CAS 147404-76-0 - Request Quote
Azilsartan Impurity A
| SZ CAT No: | SZ-A004002 |
| CAS No | 147404-76-0 |
| Mol.F. | C25H23N3O4 |
| Mol.Wt. | 429.5 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Azilsartan Impurity A is chemically Methyl 1-((2'-carbamoyl-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate. Azilsartan Impurity A is supplied with detailed characterization data compliant with regulatory guideline. Azilsartan Impurity A can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Azilsartan.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 147404-76-0
Purchase 147404-76-0
Order 147404-76-0
Enquire 147404-76-0
price of 147404-76-0
147404-76-0 Supplier
147404-76-0 Manufacturer
147404-76-0 Exporter
buy high quality Azilsartan Impurity A
Purchase Azilsartan Impurity A
Azilsartan Impurity A suppliers
Azilsartan Impurity A manufacturers
Azilsartan Impurity A price
Order Azilsartan Impurity A
Enquire Azilsartan Impurity A
Azilsartan Impurity A cost
Azilsartan Impurity A Supplier
Azilsartan Impurity A Distributor
Azilsartan Impurity A for Method Validation
Azilsartan Reference Standard
Azilsartan Impurity A for ANDA Filing
Azilsartan Impurity A for Forced Degradation Studies
Azilsartan Impurity A Identification Standards
Azilsartan Impurity A for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.